✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹46 Cr.
P/E
29.36

Key Ratios

Market cap
Market cap
46.00 Cr
PE
PE
29.36
Prom Holding
Prom Holding
42.90 %
ROE (%)
ROE (%)
3.60
ROCE (%)
ROCE (%)
5.11
Div Yield (%)
Div Yield (%)
1.34
Sales
Sales
66.85 Cr
OPM (%)
OPM (%)
4.31 %
Debt to Equity
Debt to Equity
-
About
Sandu Pharmaceuticals Limited was incorporated in India on November 15, 1985. The company is m… Read more
Low
52
52W Range
High
65
  • Sandu Pharmaceutical
  • Deccan Health Care
  • Roopa Industries

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Sandu Pharmaceuticals Ltd. Business

Sandu Pharmaceuticals Limited, incorporated in India in 1985, manufactures and trades Ayurvedic medicines under the brand name SANDU with a manufacturing plant in Goa.

Sandu Pharmaceutical major competitors are Deccan Health Care, Roopa Industries, JFL Life Sciences, Kabra Drugs, iStreet Network, Medicamen Organics, Medistep Healthcare.
Market Cap of Sandu Pharmaceutical is ₹46 Crs.
While the median market cap of its peers are ₹44 Crs.

Sandu Pharmaceutical seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material